Mundipharma hosts event in Morocco to bring awareness to cancer care innovation

Mundipharma, an international pharmaceutical leader in pain management, recently hosted the third Cancer Care Summit in Morocco on Oct. 21-22.

The event focused on showcasing major developments in cancer patient care and highlighting the importance of innovation in cancer care medicine.  

More than 180 global health care professionals attended the event. Experts in oncology and palliative care from 12 Middle East and Africa (MENA) countries came together to share their expertise and the latest evidence-based research on common cancer-related issues.
 
“We are committed to innovating the way cancer care is perceived and have managed and to help health care providers design, deliver and maintain cancer care services while improving patient experience,” Dr. Ashraf Allam, regional vice president at Mundipharma for the Middle East and Africa, said. “We have synergized our efforts through combining different disease areas together and emphasized our commitment to supporting cancer care and improving the patient's overall quality of life.”
 
The summit was accredited by the American Association of Continuing Medical Education (AACME) and included discussions on cancer pain, chemotherapy-induced nausea and vomiting, and peripheral T-cell lymphoma.